low α- M1R positive allosteric modulator

7.5 mg+ PO QD in Ph. II for Parkinson’s

from eval. of M1R PAMs w/ low cooperativity

British Journal of Clinical Pharmacology

Takeda Pharmaceutical, Cambridge, USA

Chemical structure of TAK-071

The Takeda brain-penetrant M1R positive allosteric modulator (PAM), TAK-071, was optimized for lower cooperativity (α) with the native ligand to theoretically reduce the side effect of diarrhea from M1R…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: